Moshirfar Majid, Whitehead George, Beutler Barry C, Mamalis Nick
John A. Moran Eye Center, University of Utah, Salt Lake City, Utah 84132, USA.
J Cataract Refract Surg. 2006 Jul;32(7):1233-7. doi: 10.1016/j.jcrs.2006.03.014.
We report a case of toxic anterior segment syndrome (TASS) after implantation of a Verisyse (AMO) iris-supported phakic intraocular lens (IOL). The patient presented the day after surgery with significant decreased visual acuity and severe, persistent, limbus-to-limbus corneal edema. After treatment with topical steroids, oral steroids, nonsteroidal antiinflammatory agents, and hypertonic solution, the edema resolved over the course of 2 months and best corrected visual acuity improved to 20/20. Toxic anterior segment syndrome has been reported after implantation of IOLs previously, but this new case of TASS should alert surgeons to the possibility of the syndrome after phakic IOL placement.
我们报告了1例植入Verisyse（AMO）虹膜支撑型有晶状体眼人工晶状体（IOL）后发生毒性眼前节综合征（TASS）的病例。患者在术后次日出现视力显著下降以及严重、持续的全角膜水肿。经局部使用类固醇、口服类固醇、非甾体抗炎药和高渗溶液治疗后，水肿在2个月内消退，最佳矫正视力提高到20/20。此前已有植入IOL后发生毒性眼前节综合征的报道，但这例新的TASS病例应提醒外科医生注意有晶状体眼IOL植入后发生该综合征的可能性。
